BioLife Solutions Inc.

NASDAQ: BLFS · Real-Time Price · USD
24.70
-0.62 (-2.45%)
At close: Aug 15, 2025, 12:10 PM

BioLife Solutions Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
95.39M 35.41M 19.44M 69.87M
Short-Term Investments
9.2M 16.29M 43.26M n/a
Long-Term Investments
5.62M 5.62M 6.4M 4.37M
Other Long-Term Assets
6.48M 7.99M 9.35M 9.81M
Receivables
9.17M 18.66M 33.94M 23.22M
Inventory
29.01M 43.46M 34.9M 28.34M
Other Current Assets
6M 6.8M 6.91M -229K
Total Current Assets
148.76M 120.6M 138.45M 125.86M
Property-Plant & Equipment
16.76M 32.62M 39.2M 36.8M
Goodwill & Intangibles
221.86M 245.89M 256.83M 376.89M
Total Long-Term Assets
250.73M 292.11M 311.78M 426.75M
Total Assets
399.49M 412.71M 450.23M 552.6M
Account Payables
3.57M 6.94M 15.37M 14.95M
Deferred Revenue
103K 661K 548K 814K
Short-Term Debt
12.45M 6.83M 1.81M 862K
Other Current Liabilities
3.72M 17.66M 20.71M 21.52M
Total Current Liabilities
32.73M 42.18M 44.58M 42.7M
Long-Term Debt
5M 18.31M 23.79M 6.35M
Other Long-Term Liabilities
n/a 6.5M 2.33M 4.94M
Total Long-Term Liabilities
17.84M 32.87M 41.46M 31.88M
Total Liabilities
50.58M 75.05M 86.04M 71.85M
Total Debt
30.17M 42.69M 43.71M 26.88M
Common Stock
47K 45K 43K 42K
Retained Earnings
-335.1M -313.34M -246.91M -105.02M
Comprehensive Income
24K -345K -679K -282K
Shareholders Equity
348.91M 337.66M 364.19M 480.75M
Total Investments
10.19M 21.91M 49.66M 4.37M